BlackRock Institutional Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $362M | Buy |
4,373,022
+241,763
| +6% | +$20M | 0.05% | 352 |
|
|
2016
Q3 | $382M | Buy |
4,131,259
+213,394
| +5% | +$19.7M | 0.06% | 321 |
|
|
2016
Q2 | $305M | Buy |
3,917,865
+108,349
| +3% | +$8.43M | 0.05% | 373 |
|
|
2016
Q1 | $314M | Sell |
3,809,516
-22,450
| -0.6% | -$1.85M | 0.05% | 358 |
|
|
2015
Q4 | $401M | Buy |
3,831,966
+17,925
| +0.5% | +$1.88M | 0.07% | 296 |
|
|
2015
Q3 | $402M | Buy |
3,814,041
+44,477
| +1% | +$4.68M | 0.07% | 285 |
|
|
2015
Q2 | $516M | Sell |
3,769,564
-10,496
| -0.3% | -$1.44M | 0.08% | 238 |
|
|
2015
Q1 | $471M | Buy |
3,780,060
+254,895
| +7% | +$31.8M | 0.07% | 275 |
|
|
2014
Q4 | $319M | Buy |
3,525,165
+6,906
| +0.2% | +$624K | 0.05% | 366 |
|
|
2014
Q3 | $254M | Sell |
3,518,259
-3,337
| -0.1% | -$241K | 0.04% | 422 |
|
|
2014
Q2 | $219M | Buy |
3,521,596
+46,597
| +1% | +$2.9M | 0.04% | 488 |
|
|
2014
Q1 | $237M | Buy |
3,474,999
+111,165
| +3% | +$7.58M | 0.04% | 437 |
|
|
2013
Q4 | $237M | Buy |
3,363,834
+164,980
| +5% | +$11.6M | 0.04% | 434 |
|
|
2013
Q3 | $231M | Sell |
3,198,854
-57,873
| -2% | -$4.18M | 0.04% | 410 |
|
|
2013
Q2 | $182M | Buy |
+3,256,727
| New | +$182M | 0.04% | 478 |
|